The function of HIF-1, a master regulator of metabolism, is in part modulated by Cited2. The role of Cited2 in murine embryonic stem cell (mESC) glucose metabolism remains unknown. Results: Deletion of Cited2 in mESCs results in impaired mitochondria morphology, reduced glucose oxidation, increased glycolysis, and defective mESC differentiation. Conclusion: Cited2 coordinates glucose metabolism to regulate mESC differentiation. Significance: Cited2 is a potential target for metabolic reprogramming in mESCs.
CREB-binding protein (CBP)/p300 interacting transactivator with glutamic acid (Glu) and aspartic acid (Asp)-tail 2 (Cited2) was recently shown to be essential for gluconeogenesis in the adult mouse. The metabolic function of Cited2 in mouse embryonic stem cells (mESCs) remains elusive. In the current study, the metabolism of glucose was investigated in mESCs, which contained a deletion in the gene for Cited2 (Cited2 ⌬/؊ ). Compared with its parental wild type counterpart, Cited2 ⌬/؊ ESCs have enhanced glycolysis, alternations in mitochondria morphology, reduced glucose oxidation, and decreased ATP content. Cited2 is recruited to the hexokinase 1 (HK1) gene promoter to regulate transcription of HK1, which coordinates glucose metabolism in wild type ESCs. Reduced glucose oxidation and enhanced glycolytic activity in Cited2 ⌬/؊ ESCs correlates with defective differentiation during hypoxia, which is reflected in an increased expression of pluripotency marker (Oct4) and epiblast marker (Fgf5) and decreased expression of lineage specification markers (T, Gata-6, and Cdx2). Knockdown of hypoxia inducible factor-1␣ in Cited2 ⌬/؊ ESCs re-initiates the expression of differentiation markers T and Gata-6. Taken together, a deletion of Cited2 in mESCs results in abnormal mitochondrial morphology and impaired glucose metabolism, which correlates with a defective cell fate decision. CREB 2 -binding protein (CBP)/p300 interacting transactivator with glutamic acid (Glu) and aspartic acid (Asp)-tail 2 (Cited2) is a multifunctional protein essential for mouse embryogenesis (1) (2) (3) (4) . Embryos with a deletion of Cited2 have defects in multiple organs including the heart, liver, and adrenal glands and do not survive beyond E14.5 (1) (2) (3) (4) . A knock-out of Cited2 in mice causes defects in arterial and ventricular septum and outflow tract, which are responsible for embryonic lethality of a Cited2 gene deletion (1, 3, 4) . By interacting with hepatocyte nuclear factor 4␣, Cited2 regulates lipid and carbohydrate metabolism in embryos (2) . Interestingly, embryos in which the gene for Cited2 has been deleted have no adrenal gland (1) . In adult mice, hematopoietic stem cells are metabolically inactive, as evidenced by cell quiescence, whereas the maintenance of hematopoietic stem cells is sensitive to changes in the metabolism of glucose and fatty acids (5, 6) . Importantly, we and others have shown that Cited2 regulates quiescence and apoptosis in adult hematopoietic stem cells via HIF-1 and p53-dependent mechanisms (7, 8) . Recently, by adenovirus-mediated delivery of Cited2 small hairpin RNA (shRNA) to mouse hepatocytes, it was demonstrated that Cited2 regulates gluconeogenesis by interacting with histone acetyltransferase GCN5 to affect acetylation and activity of peroxisome proliferative-activated receptor ␥ co-activator 1␣ (PGC-1␣) (9) .
Although Cited2 has been suggested as a crucial player in the regulation of gluconeogenesis, the role of Cited2 in glucose metabolism, especially glycolysis and oxidation phosphorylation in murine embryonic stem cells (mESC) remains elusive. The gene for Cited2 is present on chromosome 6q.23, a chromosomal region that is associated with genes involved in the control of insulin concentrations and insulin resistance in Mexican-Americans (10, 11) . Indeed, Cited2 mRNA was down-reg-ulated by insulin in skeletal muscle of 17 healthy volunteers exposed to acute physiological hyperinsulinemia (10) . In contrast, Cited2 mRNA was one of the top five up-regulated transcripts in 8 Type 2 diabetics, as compared with 8 non-diabetic subjects after low-dose insulin infusion (12) . These studies strongly suggest that Cited2 plays an important role in insulinmediated signaling pathways that regulate glucose metabolism in humans.
ESCs represent a unique cell population that are characterized by their small size, rapid proliferation, and resistance to senescence, which provides a robust platform for metabolic studies (13) . In the undifferentiated state, the majority of glucose (80%) enters the glycolytic pathway to maintain ESC proliferation and self-renewal (14, 15) . Lin-28 and c-Myc, two proteins that determine ESC pluripotency, also regulate glucose metabolism, suggesting a possible connection between the rate of glucose utilization and ESC self-renewal (16 -18) . Moreover, metabolic fluctuations exist at different time points of ESC differentiation. In the early stages of differentiation into epiblast stem cells, 98% of glucose is consumed for lactate production (14) . At mid-to-late differentiation, ESCs undergo a metabolic switch from glycolysis to mitochondrial oxidative phosphorylation to provide sufficient ATP for differentiation (19, 20) . A metabolic switch from oxidative phosphorylation to glycolysis would thus favor reprogramming of terminally differentiated mouse fibroblasts to induced pluripotent stem cells (21) . Although the metabolic dynamics is critical for proper ESC differentiation, little is known about how ESC pro-differentiation factors modulate glucose homeostasis during this process.
Cited2 was recently characterized as a pro-differentiation factor in the mouse ESCs (22, 23) . In this study, we report that mESCs with a deletion in the gene for Cited2 (Cited2 ⌬/Ϫ ) have swollen mitochondria, increased mitochondrial number, and reduced mitochondrial function as reflected by a reduced rate of glucose oxidation. Impaired glucose oxidation and increased glycolytic activity in Cited2 ⌬/Ϫ ESCs is associated with defective differentiation during hypoxia. In particular, Cited2 ⌬/Ϫ ESCs display increased mRNA expression of pluripotency marker (Oct4) and epiblast marker (Fgf5), and defective mRNA induction of lineage markers (T, Gata-6, and Cdx2). Knockdown of hypoxia inducible factor (HIF)-1␣ in Cited2 ⌬/Ϫ ESCs re-initiates expression of lineage markers T and Gata-6. Furthermore, Cited2 is recruited to the HK1 gene promoter to directly modulate the expression of HK1, a key enzyme in glycolysis. Thus, Cited2 coordinates glucose metabolism, pluripotency, differentiation, and cell proliferation and is a potential target for metabolic reprogramming in ESCs.
EXPERIMENTAL PROCEDURES
ES Cell Culture and Induced Differentiation-Cited2 Flox/ϩ (hereafter referred to as wild type, WT) and Cited2 ⌬/Ϫ ESC (clone number 3) were utilized for most of the experiments performed in this study. To maintain ESCs under undifferentiated status in feeder-free culture system, WT and Cited2 ⌬/Ϫ ESCs stably transfected with Oct4-IRES-GFP-Puro R reporter plasmid were grown on gelatin-coated plates in complete ESC media (DMEM (Invitrogen) containing 25 mM glucose, 15% ESqualified FBS (Germini), 2.5 mM Glutamax (Invitrogen), 1ϫ non-essential amino acids (Invitrogen), 55 M 2-mercaptoethanol (Invitrogen), and 1,000 IU/ml of ESGRO leukemia inhibitory factor (Millipore)). ESCs were periodically selected with puromycin to maintain a population of undifferentiated ESC. ESCs were induced to differentiate via a methylcellulose-based method as described previously (22) . For hypoxia experiments, ESCs were cultured or induced to differentiate in an incubator with an adjustable oxygen concentration, as described elsewhere (24) .
Measurement of Glucose, Lactate, Glycolytic Activity, and Cell Proliferation-Undifferentiated ES cells were cultured in 0.1% gelatin-coated dishes and media was collected at the indicated time points for measurement of glucose and lactate, as described elsewhere (25) (26) (27) . For primary embryoid bodies (EB) that were differentiating in methylcellulose-based semisolid media, the EBs were re-suspended at 37°C in PBS and centrifuged at 300 ϫ g for 5 min. The supernatant was diluted 10-fold for the measurement of glucose and lactate via spectrophotometric methods. For glucose measurement, the sample was mixed with trithanolzmine buffer containing MgSO 4 , ATP/NADP, and Glc-6-PDH to record initial absorbance at 340 nm. Hexokinase solution was then added and the final absorbance was read when the absorbance was stabilized for 15 s. The absorbance difference was used for the calculation of glucose concentration. For lactate measurement, the sample was mixed with hydrazine/glycine buffer and NAD solution in a test tube and extinction E1 at 340 nm was recorded. After adding lactate dehydrogenase (LDH), the mixture was incubated at 37°C for 30 min and the extinction E2 was determined. Extinction difference between E1 and E2 was then used to calculate lactate concentration. The relative percentage of glucose metabolized to lactate was utilized for the assessment of glycolytic activity (relative glucose conversion to lactate ϭ [lactate production (mol)]/[2ϫ glucose consumption (mol)] ϫ 100%). Cell proliferation was assessed by a CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega).
Oxidation of Glucose, Acetate, and Glutamate to Carbon Dioxide-The oxidation of [U-14 C]-glucose, [2-14 C]acetate, and [U-14 C]glutamate to 14 CO 2 was determined as previously described (28) . In brief, 1-6 ϫ 10 6 cells were resuspended in 2 ml of DMEM (11966-025, Invitrogen) in a flask that contained [U-14 C]glucose (5 mM, 0.5 Ci), [2-14 C]acetate (1 mM, 0.5 Ci), or [U-14 C]glutamate (1 mM, 0.5 Ci) and incubated at 37°C for 4 h. The experimental procedures and device used for release of 14 CO 2 trapping were described elsewhere (28) .
Electron Microscopy (EM)-Undifferentiated ESCs (5 ϫ 10 4 cells) were seeded on gelatin-coated, 12-well plates and cultured for 2 days. Cells were fixed immediately with a triple aldehyde-dimethyl sulfoxide fixative and processed by the Case Western Reserve University School of Medicine Electron Microscopy Core Facility.
ATP Measurement-The total ATP content of ESCs was determined by using an adenosine 5Ј-triphosphate bioluminescent somatic cell assay kit (Sigma) as described elsewhere (29) .
Oxygen Consumption Assay-ESC oxygen consumption was determined using the Seahorse XF-24 Bioanalyzer and Oxgraph-2K-based platform. For the Seahorse XF-24-based assay, 120,000 undifferentiated ESCs were seeded on Cel-Tek (BD)-coated XF-24 plates for 1 h. The assays were performed in the unbuffered XF-24 assay media in the presence of 25 mM glucose, 2.5 mM pyruvate, and 2 mM L-alanyl-glutamine (Glutamax). The rate of oxygen consumption at the basal level and upon treatment with oligomycin, p-trifluoromethoxy carbonyl cyanide phenylhydrazone (FCCP), or rotenone was recorded sequentially. Respiration by ESCs was determined using an Oxygraph-2K-based workshop (OROBOROS, Innsbruck, Austria) by re-suspending cells in MiR05 respiration buffer (20 mM HEPES, 10 mM KH 2 PO 4 , 110 mM sucrose, 20 mM taurine, 60 mM K-lactobionate, 0.5 mM EGTA, 3 mM MgCl 2 , 0.1% fatty acid-free BSA) (30) at the cell density of 1 ϫ 10 6 /ml. Prior to permeabilization, the basal level of oxygen consumption was monitored and the cells were then permeabilized with digitonin and different mitochondrial respiration substrates were added sequentially to determine the level of oxygen consumption (31) . Total protein mass determined by a Bradford assay (Fisher) was used for the normalization of the oxygen consumption rate as described previously (32) .
Flow Cytometry-A MitoPT TM TMRM assay kit (Immuno-Chemistry Technologies) was used to determine the mitochondria membrane potential. The level of the reduced form of reactive oxidative species in mitochondria was determined by MitoTracker Orange CM-H2TMRos staining (Invitrogen, catalogue number M7511). Cells were incubated with TMRM (20 nM) or CM-H2TMRos (100 nM) at 37°C for 30 min in the dark and subjected to analysis using a flow cytometer LSR-II (BD Biosciences).
Genomic DNA Extraction, RNA Isolation, and Quantitative Real-time PCR-Genomic DNA was extracted using Archive-Pure DNA cell/tissue kit (5 PRIME GmbH) and RNA was eliminated by RNase treatment. TRIzol reagent (Invitrogen) was used for RNA isolation. One g of the isolated RNA was reverse transcribed to cDNA using a High Capacity RNA-to-cDNA Kit (Applied Biosystems) and SYBR Green-based real-time PCR (Roche Applied Science) was performed using a Bio-Rad PCR cycler. Primer sequences used for this study are available upon request.
Lentivirus Production and HIF-1␣ shRNA Knockdown-293T cells were co-transfected with pLKO-based GFP or with a HIF-1␣ shRNA plasmid (33) and viral packaging and envelope plasmids, using calcium phosphate-mediated gene delivery to produce lentivirus. After 72 h of incubation, the lentivirus supernatant was filtered and used for infection of ESCs. Stable cell lines with a knockdown of HIF-1␣ in ESCs were obtained by puromycin selection and validated with real-time PCR and Western blot assays.
Western Blot-Undifferentiated ESCs (5 ϫ 10 5 cells) were seeded on gelatin-coated 12-well plates. After overnight incubation, cells were replenished with complete ESC media or Hanks' balanced salt solution for 6 h. Cell lysates were harvested with RIPA buffer in the presence of a protease inhibitor mixture (eComplete, Roche Applied Science). Western blots were probed with antibodies to LC3 and p62 (Cell Signaling).
Chromatin Immunoprecipitation (ChIP) Assay-ChIP assay was performed by following a standard protocol (34) . Briefly, protein-DNA complexes in WT ESCs were cross-linked with 1% paraformaldehyde and chromatins were sonicated to the average length of 300 -500 base pairs. Chromatins were further immunoprecipitated with IgG or CITED2 antibody (R&D Systems) and the enrichment of CITED2 on the hexokinase 1 promoter region was determined by quantitative PCR and normalized to the IgG control (set as 1.0). The four regions randomly selected on the HK1 promoter were: R2, Ϫ2502 to Ϫ2284; R3, Ϫ1655 to Ϫ1452; R6, Ϫ831 to Ϫ609; and R7, Ϫ472 to Ϫ365 (all are relative distance to transcription start site of the HK1 gene).
Statistical Analysis-Student's t test was used to compare the difference between two groups. p Ͻ 0.05 is considered as a statistically significant difference.
RESULTS
Enhanced Aerobic Glycolysis and Reduced Glucose Oxidation in Undifferentiated Cited2 ⌬/Ϫ ESCs-Media in the three independent Cited2 ⌬/Ϫ ESC clones previously generated via homologous recombination was noted to become acidic during EBinduced differentiation, as compared with the WT counterpart, suggesting that deletion of Cited2 may affect the rate of glucose conversion to lactate in ESCs. To gain insights into differential glucose metabolism between WT and Cited2 ⌬/Ϫ ESCs, glucose consumption and the conversion of glucose to lactate and carbon dioxide were measured. During 3 h of incubation, ESCs with Cited2 deletion consumed ϳ20% more of glucose ( Fig. 1A ) and consequently produced ϳ30% more lactate (Fig. 1B) . Besides conversion to lactate by LDH, glucose-derived pyruvate can be oxidized in the mitochondria to acetyl-CoA by the pyruvate dehydrogenase complex, which can then be oxidized to CO 2 in the tricarboxylic acid (TCA) cycle. Compared with WT ESCs, undifferentiated Cited2 ⌬/Ϫ ESCs oxidized 75% less glucose to carbon dioxide (Fig. 1C ). Unlike HEK293 cells (positive control), WT and Cited2 ⌬/Ϫ ESCs had a minimal capacity to oxidize [2-14 C]acetate to carbon dioxide ( Fig. 1D ). [U-14 C]Glutamate also used a substrate to determine the rate of oxidation of 5-carbon intermediates in the TCA cycle. When [U-14 C]glutamate was provided in glucose-free DMEM, glutamate oxidation was barely detectable in WT and Cited2 ⌬/Ϫ ESCs (Fig. 1E ). In addition, the ATP content was reduced by ϳ30% in Cited2 ⌬/Ϫ ESCs (Fig. 1F ). These results show that WT and Cited2 ⌬/Ϫ ESCs have a differential capacity to metabolize glucose during short incubation periods, suggesting a role of Cited2 in controlling glucose metabolism in mESCs.
Mouse ESCs possess bivalent metabolic traits (glycolysis and oxidative phosphorylation) to regulate pluripotency, proliferation, and differentiation (35) . Because Cited2 deletion did not affect pluripotency in undifferentiated ESCs from our previous study (22) , we tested whether enhanced glycolysis in Cited2 ⌬/Ϫ ESCs supports ESC proliferation and survival. Cell proliferation was similar in WT and Cited2 ⌬/Ϫ ESCs during 48 h of incubation, whereas Cited2 ⌬/Ϫ ESCs had modestly increased cell proliferation at 72 h of incubation compared with WT control (Fig.  1G) . In dependent on aerobic glycolysis for maintaining survival and pluripotency (15) , WT and Cited2 ⌬/Ϫ ESCs treated with specific glycolysis inhibitor 2-deoxyglucose (2-DG) were not able to retain undifferentiated colonies with positive alkaline phosphatase (AP) staining ( Fig. 1H ). Collectively, these data demonstrate that Cited2 ⌬/Ϫ ESCs display enhanced aerobic glycolysis and reduced glucose oxidation, and that alternations in glucose metabolism in undifferentiated Cited2 ⌬/Ϫ ESCs did not affect ESC pluripotency and proliferation.
Cited2 ⌬/Ϫ ESCs Have Altered Morphology and an Increase in the Number of Mitochondria-A reduced rate of glucose oxidation by Cited2 ⌬/Ϫ ESCs suggested that mitochondrial functions might be affected in these cells. We next compared the ultrastructure of WT and Cited2 ⌬/Ϫ ESCs by EM. WT ESCs had a low number of mitochondria with typical morphology, which is consistent with previous reports (36) (Fig. 2, A and B) . Interestingly, swollen mitochondria and an increased number of mitochondria were found in Cited2 ⌬/Ϫ ESCs (Fig. 2, A-C) . The ratio of total mitochondrial DNA (mtDNA) copy to nuclear DNA copy reflects mitochondrial content. The increased mitochondrial number parallels the higher ratio of the mtDNA copy (ND1 and cytochrome b) to nuclear DNA (18S rDNA) copy in Cited2 ⌬/Ϫ ESCs (Fig. 2D ). Swollen mitochondria are associated with reduced mitochondrial membrane potential, increased apoptosis, accumulated ROS in the mitochondria, and are defective autophagy in multiple cell types (37) (38) (39) (40) . To test whether the mitochondrial membrane potential is affected by abnormal morphology, we performed tetramethylrhodamine methyl ester (TMRM) staining and found that mitochondrial membrane potential was increased by ϳ20% in Cited2 ⌬/Ϫ ESCs (Fig. 3A) . The increased TMRM staining of Cited2 ⌬/Ϫ ESCs and comparable basal apoptosis in WT and Cited2 ⌬/Ϫ ESCs (22) suggests that the swollen mitochondria in Cited2 ⌬/Ϫ ESCs are independent of apoptosis. Furthermore, WT and Cited2 ⌬/Ϫ ESCs had comparable levels of the reduced form of ROS in their mitochondria (Fig. 3B) , indicating that ROS is not the main contributor for the swollen mitochondria in these cells. Swollen mitochondria are associated with accumulated ubiquitin and mitophagy markers, such as LC3 and p62/SQSTM1 (39, 40) . In complete ESC media, Cited2 ⌬/Ϫ ESCs had increased conversion of LC3-I into LC3-II, the lipidated form of LC3, whereas p62 protein expression was comparable in WT and Cited2 ⌬/Ϫ ESCs (Fig. 3C ). Upon nutrient deprivation, Cited2 ⌬/Ϫ ESCs not only had an increased rate of conversion of LC3-I into LC3-II but also an accumulation of p62 protein (Fig. 3C ). Taken together, Cited2 ⌬/Ϫ ESCs display altered mitochondrial morphology and number, which is associated with a reduced rate of glucose oxidation, increased mitochondrial membrane potential, and impaired autophagy.
Cited2 ⌬/Ϫ ESCs Have an Enhanced Oxygen Consumption Capacity-Because we observed reduced glucose oxidation, swollen mitochondria, and an increased number of mitochondria in Cited2 ⌬/Ϫ ESCs, we tested whether these alternations are coupled with oxygen consumption. The rate of basal oxygen consumption (OCR) was comparable for adherent WT and Cited2 ⌬/Ϫ ESCs in the media containing 25 mM glucose, 2.5 mM pyruvate, and 2 mM L-alanyl-glutamine (Glutamax) (Fig. 3D) . OCR was blocked by the ATP synthase inhibitor oligomycin to a similar extent in WT and Cited2 ⌬/Ϫ ESCs. In the presence of 0.5 M FCCP, Cited2 ⌬/Ϫ ESCs exhibited modestly increased OCR as compared with WT control cells, indicating that Cited2 ⌬/Ϫ ESCs retained enhanced oxygen consumption capacity. Upon rotenone treatment, OCR was similarly inhibited in WT and Cited2 ⌬/Ϫ ESCs; thus the enhanced capacity for oxygen consumption correlates with the increased mitochondrial number and membrane potential observed in Cited2 ⌬/Ϫ ESCs, whereas oxygen consumption in swollen mitochondria is independent of reduced glucose oxidation observed in Cited2 ⌬/Ϫ ESCs.
To further monitor mitochondrial respiration mediated by different substrates and inhibitors in permeabilized ESCs, we utilized Oxygraph-2K to measure ESC oxygen consumption in the MiR05 buffer. Compared with WT control, basal oxygen consumption of Cited2 ⌬/Ϫ ESCs in the MiR05 mitochondria buffer was reduced ( Fig. 3E) , whereas maximal mitochondrial respiration capacity upon FCCP treatment was also enhanced in intact Cited2 ⌬/Ϫ ESCs, as compared with the WT control cells (data not shown). Digitonin-mediated cellular permeabilization resulted in ϳ50% reduction in OCR in WT and Cited2 ⌬/Ϫ ESCs, reflecting the typical response to endogenous ADP depletion by digitonin. The addition of ADP and glutamate did not stimulate oxygen consumption in WT and Cited2 ⌬/Ϫ ESCs, whereas FCCP treatment of permeabilized ESCs caused only a ϳ20% increase in mitochondrial respiration in both groups (Fig. 3E) inhibitor of Complex I of the respiratory chain, indicating that both ESCs maintain mitochondrial respiration. Collectively, intact Cited2 ⌬/Ϫ ESCs have modestly increased oxygen consumption compared with the WT control, whereas permeabilized WT and Cited2 ⌬/Ϫ ESCs do not respond to ADP stimulation, yet remain sensitive to rotenone inhibition of oxygen consumption. Cited2 Regulates Expression of Metabolism-associated Genes in Undifferentiated ESCs-Because undifferentiated Cited2 ⌬/Ϫ ESCs exhibited enhanced aerobic glycolysis, we investigated whether glycolysis associated genes are affected in these cells. The activity of LDH is known to be elevated during mouse embryonic development from the one-cell stage to blastocyst formation (embryonic day 0 to 3-4), whereas there is an increase in the activity of hexokinase (HK) (14) . Glycogen synthase activity is decreased during embryonic day 3-4, whereas phosphofructokinase 1 (PFK1) activity remains the same during embryonic development to blastocysts (14) . We determined mRNA transcripts of HK (1 to 4 isoforms), PFK1 (liver (L) and muscle (M) isoforms), pyruvate kinase (PK), LDH (A to D isoforms) in Cited2 ⌬/Ϫ and reconstituted Cited2 ⌬/Ϫ ESCs by stably transfected with Cited2 expression plasmid. We have previously shown that Cited2 regulates Oct4 gene expression in ESCs (14) . It is therefore not surprising that expression of the gene for HK1, an Oct4 target gene (41) , was reduced to 1.6-fold in reconstituted Cited2 ⌬/Ϫ ESCs (Fig. 4A ). PFK1 is a rate-limiting enzyme in glycolysis; we noted that mRNA for PFK1-L, but not PFK1-M was increased to 2-fold in reconstituted Cited2 ⌬/Ϫ ESCs (Fig. 4A ). In addition, the mRNA for PK, another key regulatory enzyme in glycolysis was not affected in reconstituted Cited2 ⌬/Ϫ ESCs (Fig. 4A ). LDHB is a major regulator of glycolysis in normal and cancer cells (42) (43) (44) and LDHB mRNA was not changed in reconstituted Cited2 ⌬/Ϫ ESCs (Fig. 4A ). Furthermore, reintroduction of Cited2 significantly enhanced the reduced level of glucose oxidation in Cited2 ⌬/Ϫ ESCs (Fig.  4B) . The direct role of Cited2 in the regulation of HK1 gene transcription was further evidenced by ϳ5-fold enrichment by Cited2 antibody against IgG control on the R3 region of the HK1 promoter ( Fig. 4C) , with modest enrichment in the R7 region and no enrichment in the R2 and R6 regions of the HK1 gene promoter (Fig. 4C) . Collectively, Cited2 is recruited to the HK1 gene promoter to directly control HK1 gene expression and regulate glucose metabolism.
Increased Glycolytic Activity and Impaired Hypoxic Differentiation in Cited2 ⌬/Ϫ ESCs-Because glucose metabolism was altered by Cited2 deletion but did not affect mESC pluripotency and proliferation in undifferentiated ESCs, we further explored whether enhanced glycolysis and reduced glucose oxidation caused by Cited2 deletion impact ESC differentiation. During ESCs differentiating to cardiomyocytes, the rate of lactate production, normalized by time and total protein mass was reported to be reduced to 2-fold, supporting the notion that metabolic reprogramming is essential for proper ESC differentiation (19) . We previously demonstrated that Cited2 ⌬/Ϫ ESCs exhibit defective cardiomyocyte and hematopoietic differentiation during normoxia (22) . In WT and Cited2 ⌬/Ϫ EBs favoring cardiomyocyte differentiation, glucose oxidation was reduced by 30% in Cited2 ⌬/Ϫ EBs compared with the WT control (Fig.  5A) , indicating Cited2 ⌬/Ϫ EBs retain defects in glucose oxida-tion in both undifferentiated and differentiating Cited2 ⌬/Ϫ ESCs. To test whether differentiating Cited2 ⌬/Ϫ ESCs have changes in glycolysis as ESCs in the undifferentiated state, we took advantage of ESC differentiation during hypoxia based on two considerations. First, hypoxia supports ESCs early differentiation by modulating glycolysis (35) . Induction of metabolism-associated genes (PDK1, LDHA, and PYGL) in ESCs by HIF-1␣ stabilization enhances glycolytic metabolism, which in turn results in ESC transition to epiblast stem cells. Second, Cited2 has been well characterized as a negative regulator of HIF-1 by competitive binding of HIF-1␣ to the CH1 domain of CBP/p300 (45) . To examine whether hypoxia regulates glucose metabolism in Cited2 ⌬/Ϫ EBs, the concentrations of glucose and lactate during differentiation under hypoxic conditions were measured. Compared with WT controls, Cited2 ⌬/Ϫ EBs had a reduced rate of glucose consumption but the rate of lactate production was increased in Cited2 ⌬/Ϫ EBs (Fig. 5, B and  C) , suggesting that a large proportion of glucose might be used for oxidative phosphorylation to supply ATP essential for differentiation in WT EBs. Indeed, measurement of glycolytic activity by the percentage of glucose converted to lactate revealed that ϳ40% of glucose was converted to lactate in WT EBs (Fig. 5D ), whereas undifferentiated WT ESCs consumed ϳ80% of glucose for glycolysis, indicating that WT EBs experienced a metabolic switching during differentiation in agree- ment with a previous study (46) . In contrast, the majority of glucose (ϳ95%) was still converted to lactate in Cited2 ⌬/Ϫ EBs (Fig. 5D ) as did in undifferentiated Cited2 ⌬/Ϫ ESCs. Furthermore, ϳ2.5-fold increase in glycolytic activity resulted in ϳ4.5fold higher cell proliferation rate in Cited2 ⌬/Ϫ EBs (Fig. 5E ). These results suggest that deletion of Cited2 results in reduced glucose oxidation and enhanced glycolytic activity in both undifferentiated and differentiating ESCs.
We next tested whether metabolic defects of Cited2 ⌬/Ϫ ESCs affects proper ESC differentiation under hypoxia by examining the expression of the pluripotency gene (Oct4) and differentiation genes (Fgf5, T, Gata-6, and Cdx2) (47) . Oct4 gene expression was gradually reduced in differentiating WT ESCs during hypoxia, indicative of proper ESC differentiation (Fig. 6A) . In contrast, the expression of Oct4 remained high in differentiating Cited2 ⌬/Ϫ ESCs (Fig. 6A) , which is consistent with our previous report that Cited2 regulates expression of the Oct4 gene to control ESC differentiation during normoxia (22) . Fgf5, a primitive epiblast marker for ESC differentiation, was induced in WT EBs at day 3.5 and the expression level was gradually reduced at EB days 4.5 and 5.5. Compared with WT controls, Fgf5 mRNA was induced to similar levels at EB day 3.5, whereas there was increased induction of Fgf5 at EB days 4.5 and 5.5 in Cited2 ⌬/Ϫ EBs. Induction of T and Gata-6, a mesoderm marker and an endoderm marker, respectively, was significantly reduced in Cited2 ⌬/Ϫ EBs at days 3.5 and 4.5 as compared with WT controls ( Fig. 6A ). Cited2 ⌬/Ϫ EBs had a lower level of expression of Cdx2, a trophectoderm marker, at EB days 3.5 and 4.5, whereas there was a higher induction at EB day 5.5 compared with WT controls (Fig. 6A ). Because Cited2 ⌬/Ϫ EBs had a defective induction of the mesoderm marker T gene, we performed a colony formation unit (CFU) assay to examine whether differentiation to hematopoietic cells, a bona fide mesoderm lineage, is affected. Indeed, cfu-erythroid (CFU-E), CFU-granulocytemacrophage (CFU-GM), and CFU-mixed colonies were significantly reduced in Cited2 ⌬/Ϫ ESCs under hypoxic conditions (Fig. 6B) . Collectively, we show that Cited2 ⌬/Ϫ ESCs have impaired differentiation during hypoxia, as evidenced by their inability to down-regulate pluripotency genes, an improper induction of lineage marker genes, and defective hematopoietic cell differentiation. Taken together, increased glycolytic activity, reduced glucose oxidation, and the inability to switch off glycolysis in differentiating Cited2 ⌬/Ϫ ESCs may contribute to defective cell lineage specification.
HIF-1 Regulates Expression of Differentiation Genes in Cited2 ⌬/Ϫ ESCs-Because Cited2 ⌬/Ϫ ESCs during hypoxic differentiation had increased glycolytic activity and defective gene expression, we next investigated whether HIF-1␣ plays a major role in the initiation of differentiation program in Cited2 ⌬/Ϫ ESCs. During hypoxic differentiation, a knockdown of HIF-1␣ ( Fig. 7A ) had no effect on the aberrant activation of Oct4 mRNA in Cited2 ⌬/Ϫ EBs (Fig. 7B ). The expression of Fgf5 was not affected at EB days 3.5 and 4.5 but was further up-regulated at EB day 5.5 in Cited2 ⌬/Ϫ EBs with HIF-1␣ knockdown (Fig. 7B) . Interestingly, defective induction of T and Gata-6 mRNA in Cited2 ⌬/Ϫ EBs was significantly resumed (Fig. 7B) , whereas impaired trophectoderm marker Cdx2 mRNA induction in Cited2 ⌬/Ϫ EBs was not affected by HIF-1␣ knockdown (Fig. 7B) . Thus, during hypoxic differentiation, a knockdown of HIF-1␣ modestly corrects the defective induction of the lineage differentiation genes T and Gata-6 in Cited2 ⌬/Ϫ EBs, indicating that HIF-1 is in part responsible for the defective mesoderm/endoderm differentiation in Cited2 ⌬/Ϫ ESCs.
DISCUSSION
Cited2 is a well established transcription co-activator that competes with HIF-1␣ for binding to the CH1 domain of CBP/ p300 (45) . Accordingly, a knock-out of p300 or Cited2 in ESCs results in several similar phenotypes, such as delayed silencing of ESC pluripotency genes and defective hematopoietic differentiation (22, 48, 49) . The role of p300 in ESC metabolism remains elusive. By monitoring glucose consumption and extracellular lactate production, we found that undifferentiated Cited2 ⌬/Ϫ ESCs metabolize ϳ20% more glucose via aerobic glycolysis than WT counterparts, with a concomitant regulation of glycolysis-associated genes, such as HK1 and PFK1-L. HK1 is a target gene of Oct4 and HIF-1 (41, 50) , two transcription factors previously shown to be modulated by Cited2 (8, 22) . A ChIP assay indicated that Cited2 is recruited to the HK1 gene promoter, further supporting the direct role of Cited2 in coordinating HK1 expression and glucose metabolism. Cited2 deletion enhanced glycolysis and reduced glucose oxidation but did not affect mESC pluripotency and proliferation in undifferentiated ESCs, whereas these metabolic alternations impaired mESC differentiation through silence of pluripotency genes, activation of lineage specification genes, and cell proliferation.
During hypoxia, mammalian cells undergo glycolysis for energy production and HIF-1 is one of the major genes involved in this metabolic event (51) . Cited2 competes with HIF-1␣ in binding to the CH1 domain of CBP/p300 and thus modulates key biological functions in heart, eye, and hematopoietic stem cells (8, (52) (53) (54) . HIF-1 is responsible for controlling the rate of glycolysis in ESC lines with gain-or loss-of-function of HIF-1␣. In HIF-1␣ Ϫ/Ϫ ESCs, the induced expression of genes (including Glut1, HK1, HK2, LDHA, and PGK1) involved in the synthesis of ATP by the conversion of extracellular glucose to intracellular lactate was abrogated in response to hypoxia and hypoglycemic stresses (55, 56) . Stabilization of HIF-1␣ in ESCs reduces mitochondrial respiration, whereas the rate of extracellular acidification is not significantly affected (35) . Importantly, enhanced HIF-1 activity in ESCs is associated with the up-regulated expression of genes encoding glycolytic enzymes and enzymes involved in energy metabolism, which primes transition of mESC to epiblast stem cell (35) . Targeted deletion of a histone deacetylase, Sirtuin-6 (SIRT6), in ESCs also results in increased glucose uptake and lactate production, whereas mitochondrial respiration is attenuated in SIRT6 Ϫ/Ϫ ESCs (57) . Mechanistically, the switch from glucose oxidation to CO 2 in the TCA cycle to glycolysis in SIRT6 Ϫ/Ϫ ESCs is mediated by increased protein stability of HIF-1␣, and the corresponding up-regulation of HIF-1 target genes, such as LDHB, PDK4, and PDK1 (57) . As a key regulator of metabolism, HIF-1 is an important transcription factor controlling multiple cell fate decisions, including mESC differentiation. During hypoxic differentiation, a knockdown of HIF-1␣ in Cited2 ⌬/Ϫ EBs mod-B FIGURE 6. Cited2 ⌬/؊ embryoid bodies have impaired differentiation during hypoxia. A, expression of genes controlling pluripotency and differentiation in WT and Cited2 ⌬/Ϫ ESCs differentiating under hypoxia. To compare down-regulation of the Oct4 gene during differentiation, the level of Oct4 mRNA in WT ESCs at day 0 (EB0) was set as 1.0. To monitor gene induction upon differentiation, mRNA expression of Fgf5, T, Gata-6, and Cdx2 in Cited2 ⌬/Ϫ EBs at day 3.5 was set as 1.0. B, Cited2 ⌬/Ϫ ESCs have defective hematopoietic differentiation during hypoxia. Primary EBs differentiated in hypoxia for 9 days were re-suspended into a single cell suspension and a cell number equivalent to 50 WT EBs were re-plated in methylcellulose media, to support hematopoietic colony formation. The respective CFUs were counted 7 days after re-plating. The experiment was repeated 4 times in triplicate and one representative set of data are presented as the mean Ϯ S.E. *, p Ͻ 0.05 compared with WT controls.
estly induced the expression of the genes for T and Gata-6, which is consistent with reports that T and Gata-6 are regulated by hypoxia (58, 59) . The appearance of the mesoderm marker T gene after a HIF-1␣ knockdown in Cited2-deleted ESCs is also consistent with our previous study that HIF-1␣ down-regulation can partially rescue the defects in cardiac development (52) . Our finding that dysregulated expression of pluripotency marker Oct4, epiblast marker Fgf5, and trophoectoderm marker Cdx2 in Cited2 ⌬/Ϫ EBs was not corrected by HIF-1␣ knockdown suggests several possibilities. 1) Hypoxic regulation in the EBs is dynamic and a critical time window for HIF-1␣ expression is thus essential for optimal ESC differentiation. 2) Fine tuning of the oxygen gradient in different regions of hypoxic EBs is crucial for ESC lineage specification. 3) HIF-1 independent mechanisms may contribute to these molecular events. Further investigation is warranted to distinguish these possibilities.
Mitochondria are the major energy hubs essential for ESC maintenance and proper differentiation. Cited2 ⌬/Ϫ ESCs have swollen mitochondria, which are also found in ESCs in which PINK1 (PTEN-induced putative kinase 1) has been deleted (60). Interestingly, both Cited2 and PINK1 genes are FOXO3a downstream targets (61) . Enhanced glycolysis in IL-3-dependent hematopoietic cell lines with a knockdown of FOXO3a is sensitive to rapamycin and FOXO3␣ regulates glycolysis by modulating TSC1 gene transcription (62) . Expression of the gene for Cited2 is regulated by FOXO3␣ (63), the mRNA of which is down-regulated by ϳ25% in Cited2 ⌬/Ϫ ESCs, with no difference in TSC1 mRNA expression (data not shown). The mechanisms responsible for similarities and differences of bio-energetic phenotypes in ESCs with deletions of these two FOXO3a target genes need to be further investigated.
Although oxidative phosphorylation is one of the typical features of ESC metabolism, the rate of oxygen consumption is extremely low in ESCs (15, 36) . Our results demonstrated that 14 C-labeled acetate and glutamate oxidation in ESCs are barely detectable; permeabilized ESCs are not responsive to ADP addition, suggesting that mitochondria in ESCs are not as active as when they are at the homeostatic state. However, oxygen consumption in the ESCs is sensitive to rotenone treatment and this may reflect the potential ability of ESCs in responding to various differentiation cues and stress conditions; for example, treatment of ESCs with CCCP affects their differentiation (64) . Furthermore, the knockdown of mitochondrial uncoupling protein 2 (UCP2) in human ESCs inhibits glycolysis, whereas the expression of ESC pluripotency markers, such as Oct4 and SSEA1, is not affected (32) . Ectopic expression of UCP2 in human ESCs reduces glucose oxidation, impairs EB formation, and hampers early differentiation (32) . Importantly, the mitochondrial metabolic stress-activated checkpoint in the control of ESC differentiation has been attributed to Ptpmt1 (proteintyrosine phosphatase, mitochondrial 1), a mitochondrial PTEN-like phosphatidylinositol phosphate phosphatase (29); enhanced aerobic glycolysis, decreased oxygen consumption, compromised mitochondrial fusion/dynamics, and blocked differentiation was observed in Ptpmt1 knock-out ESCs (29) . This implicates mitochondria as the key player in ESC differentiation and metabolic reprogramming, which may represent a unique way to modulate the fate of ESCs. To our knowledge, Cited2 is the first pro-differentiation gene whose deletion affects glucose oxidation and in turn ESC differentiation. Thus, our findings may provide a molecular basis for screening small molecules targeting Cited2 to modulate mitochondrial functions and control ESC pluripotency and differentiation.
The current investigation of the metabolic role of Cited2 also has significant implications for regenerative and clinical medicine. Metabolic reprogramming of glycolysis can greatly increase the efficiency of generating induced pluripotent stem cells from somatic fibroblasts (21) . It is thus imperative to investigate whether MEFs with a deletion in Cited2 have an enhanced rate of glycolysis and reduced glucose oxidation via the TCA cycle, as noted with differentiating EBs with Cited2 deletion. Small molecule inhibitors that target Cited2 and thus favor glycolysis may represent a novel method to increase induced pluripotent stem efficiency. On the other hand, embryonic stem cells and cancer cells are metabolically similar in that they utilize glycolysis to supply energy for proliferation. The metabolic changes in Cited2 ⌬/Ϫ ESCs may also apply to cancer cells in which the gene for Cited2 has been silenced. In human hepatoma cells, Cited2, a direct effector of peroxisome proliferator-activated receptor ␥, is down-regulated (65) . Because many cancer initiating/stem cells reside in hypoxic regions of tissues and are resistant to routine therapy, it is plausible that alterations in the activity of Cited2 could be a potential therapeutic alternative to modulate metabolic processes, as suggested by the current study.
